The medical publisher Elsevier is to investigate a U.S. senator's recent allegation that one of its journals published an article on hormone replacement therapy that was improperly ghostwritten by a drug company promoting the product. The senator, Charles Grassley, Republican of Iowa, had raised questions about the May 2003 "Editors' Choice" article in The American Journal of Obstetrics and Gynecology, published by Elsevier, which is part of the Dutch-British publishing giant Reed Elsevier.
Read article in the International Herald Tribune
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment